カテゴリ： GlobalInfoResearch, 世界, 医療/バイオ

世界の牛・羊ワクチン市場2023年：企業・地域・タイプ・用途別分析

■ 英語タイトル：Global Cattle and Sheep Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029

調査会社GlobalInfoResearch社が発行したリサーチレポート（データ管理コード：GIR23JU614）■ 発行会社/調査会社：GlobalInfoResearch
■ 商品コード：GIR23JU614
■ 発行日：2023年6月（※2025年版があります。お問い合わせください。）
■ 調査対象地域：グローバル
■ 産業分野：医薬品＆医療
■ ページ数：111
■ レポート言語：英語
■ レポート形式：PDF
■ 納品方式：Eメール（注文後2-3日）
■ 販売価格オプション（消費税別）
Single User（1名様閲覧用）USD3,480 ⇒換算￥501,120見積依頼/購入/質問フォーム
Multi User（20名様閲覧用）USD5,220 ⇒換算￥751,680見積依頼/購入/質問フォーム
Corporate User（同一法人内共有可）USD6,960 ⇒換算￥1,002,240見積依頼/購入/質問フォーム
※販売価格オプションの説明はこちらで、ご購入に関する詳細案内はご利用ガイドでご確認いただけます。
※お支払金額は「換算金額（日本円）＋消費税＋配送料（Eメール納品は無料）」です。
※Eメールによる納品の場合、通常ご注文当日～2日以内に納品致します。
※レポート納品後、納品日＋5日以内に請求書を発行・送付致します。（請求書発行日より2ヶ月以内の銀行振込条件、カード払いも可能）
※GlobalInfoResearch社の概要及び新刊レポートはこちらでご確認いただけます。
★グローバルリサーチ資料[世界の牛・羊ワクチン市場2023年：企業・地域・タイプ・用途別分析]についてメールでお問い合わせはこちら
*** レポート概要（サマリー）***

GlobalInfoResearchの最新の調査によると、世界の牛・羊ワクチンの市場規模は2022年のxxx米ドルから2029年にはxxx米ドルと推定され、xxx％の成長率で成長すると予想されます。新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を考慮しながら市場規模を推計しました。
このレポートは、世界の牛・羊ワクチン市場に関する詳細かつ包括的な分析の結果です。定量的分析と定性的分析データが、メーカー別、地域別、国別、タイプ別、用途別に記載されています。

市場は常に変化しているため、本レポートでは、競争、需要と供給の傾向、および多くの市場にわたる需要の変化に影響する主要な要因を調査しました。主要な競合他社の企業概要と製品例、および2023年の市場シェア予測も記載しました。

本レポートの主な目的は次のとおりです。
- 世界および主要国の市場機会の規模を決定するため
- 牛・羊ワクチンの成長可能性を評価するため
- 各製品および最終用途市場の将来の成長を予測するため
- 市場に影響を与える競争要因を評価するため

牛・羊ワクチン市場はタイプと用途によって区分されます。2018年～2029年において、量と金額の観点からタイプ別および用途別セグメントの売上予測データを提供します。この分析は、適格なニッチ市場をターゲットにすることでビジネスを拡大するのに役立ちます。

タイプ別セグメント
・弱毒生ワクチン、不活化ワクチン、その他

用途別セグメント
・牛、羊

主要な市場プレーヤー
・Merck、Zoetis、Boehringer Ingelheim、Ceva、CAHIC、HVRI、Ringpu Biology、Yebio、DHN、WINSUN、Elanco、Virbac、Jinyu Bio-Technology、ChengDu Tecbond、CAVAC、Kyoto Biken Laboratories

地域別セグメントは次の地域・国をカバーします。
・北米（米国、カナダ、メキシコ）
・ヨーロッパ（ドイツ、フランス、イギリス、ロシア、イタリア）
・アジア太平洋（日本、中国、韓国、インド、東南アジア、オーストラリア）
・南アメリカ（ブラジル、アルゼンチン、コロンビア）
・中東およびアフリカ（サウジアラビア、UAE、エジプト、南アフリカ）

本調査レポートの内容は計15章あります。
・第1章では、牛・羊ワクチン製品の調査範囲、市場の概要、市場の成長要因・阻害要因、および市場動向について説明します。
・第2章では、主要な牛・羊ワクチンメーカーの企業概要、2019年～2022年までの牛・羊ワクチンの価格、販売量、売上、市場シェアを掲載しています。
・第3章では、主要な牛・羊ワクチンメーカーの競争状況、販売量、売上、世界市場シェアが重点的に比較分析されています。
・第4章では、2018年～2029年までの地域別牛・羊ワクチンの販売量、売上、成長性を示しています。
・第5、6章では、2018年～2029年までの牛・羊ワクチンのタイプ別と用途別の市場規模、市場シェアと成長率を掲載しています。
・第7、8、9、10、11章では、2018年～2022年までの世界の主要国での販売量、売上、市場シェア、並びに2023年～2029年までの主要地域での牛・羊ワクチン市場予測を収録しています。
・第12章では、市場力学、成長要因、阻害要因、トレンド、ポーターズファイブフォース分析、新型コロナウイルス感染症とロシア・ウクライナ戦争の影響を掲載しています。
・第13章では、主要な原材料、主要なサプライヤー、および牛・羊ワクチンの産業チェーンを掲載しています。
・第14、15章では、牛・羊ワクチンの販売チャネル、販売業者、顧客、調査結果について説明します。

***** 目次(一部) *****

・市場概要
- 牛・羊ワクチンの概要
- タイプ別分析（2018年vs2022年vs2029年）：弱毒生ワクチン、不活化ワクチン、その他
- 用途別分析（2018年vs2022年vs2029年）：牛、羊
- 世界の牛・羊ワクチン市場規模・予測
- 世界の牛・羊ワクチン生産能力分析
- 市場の成長要因・阻害要因・動向
・メーカー情報（企業概要、製品概要、販売量、価格、売上）
- Merck、Zoetis、Boehringer Ingelheim、Ceva、CAHIC、HVRI、Ringpu Biology、Yebio、DHN、WINSUN、Elanco、Virbac、Jinyu Bio-Technology、ChengDu Tecbond、CAVAC、Kyoto Biken Laboratories
・メーカー別市場シェア・市場集中度
・地域別市場分析2018年-2029年
・タイプ別分析2018年-2029年：弱毒生ワクチン、不活化ワクチン、その他
・用途別分析2018年-2029年：牛、羊
・牛・羊ワクチンの北米市場
- タイプ別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：アメリカ、カナダ、メキシコなど
・牛・羊ワクチンのヨーロッパ市場
- タイプ別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：ドイツ、イギリス、フランス、ロシア、イタリアなど
・牛・羊ワクチンのアジア市場
- タイプ別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：中国、日本、韓国、インド、東南アジア、オーストラリアなど
・牛・羊ワクチンの南米市場
- タイプ別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：ブラジル、アルゼンチンなど
・牛・羊ワクチンの中東・アフリカ市場
- タイプ別市場規模2018年-2029年
- 用途別市場規模2018年-2029年
- 主要国別市場規模：サウジアラビア、トルコ、エジプト、南アフリカなど
・市場力学（成長要因、阻害要因、トレンド、ポーターズファイブフォース分析）
・原材料および産業チェーン
・販売チャネル、流通業者・代理店、顧客リスト
・調査の結果・結論

According to our (Global Info Research) latest study, the global Cattle and Sheep Vaccine market size was valued at USD 1729.7 million in 2022 and is forecast to a readjusted size of USD 2638.9 million by 2029 with a CAGR of 6.2% during review period. The influence of COVID-19 and the Russia-Ukraine War were considered while estimating market sizes.
Cattle and sheep vaccines are vaccines that are specifically designed for use in cattle and sheep to prevent various diseases that can affect these animals. Some of the commonly used cattle and sheep vaccines include those for diseases such as Foot and Mouth Disease (FMD), Brucellosis, Anthrax, and Clostridial diseases like Tetanus and Blackleg. These vaccines are typically administered via injection ingestion and are an important tool for maintaining the health and productivity of cattle and sheep herds.
This report is a detailed and comprehensive analysis for global Cattle and Sheep Vaccine market. Both quantitative and qualitative analyses are presented by manufacturers, by region & country, by Type and by Application. As the market is constantly changing, this report explores the competition, supply and demand trends, as well as key factors that contribute to its changing demands across many markets. Company profiles and product examples of selected competitors, along with market share estimates of some of the selected leaders for the year 2023, are provided.
Key Features:
Global Cattle and Sheep Vaccine market size and forecasts, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Cattle and Sheep Vaccine market size and forecasts by region and country, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Cattle and Sheep Vaccine market size and forecasts, by Type and by Application, in consumption value ($ Million), sales quantity (K Units), and average selling prices (US$/Unit), 2018-2029
Global Cattle and Sheep Vaccine market shares of main players, shipments in revenue ($ Million), sales quantity (K Units), and ASP (US$/Unit), 2018-2023
The Primary Objectives in This Report Are:
To determine the size of the total market opportunity of global and key countries
To assess the growth potential for Cattle and Sheep Vaccine
To forecast future growth in each product and end-use market
To assess competitive factors affecting the marketplace
This report profiles key players in the global Cattle and Sheep Vaccine market based on the following parameters – company overview, production, value, price, gross margin, product portfolio, geographical presence, and key developments. Key companies covered as a part of this study include Merck, Zoetis, Boehringer Ingelheim, Ceva and CAHIC, etc.
This report also provides key insights about market drivers, restraints, opportunities, new product launches or approvals, COVID-19 and Russia-Ukraine War Influence.
Market Segmentation
Cattle and Sheep Vaccine market is split by Type and by Application. For the period 2018-2029, the growth among segments provides accurate calculations and forecasts for consumption value by Type, and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type
Live Attenuated Vaccines
Inactivated Vaccines
Other
Market segment by Application
Cattle
Sheep
Major players covered
Merck
Zoetis
Boehringer Ingelheim
Ceva
CAHIC
HVRI
Ringpu Biology
Yebio
DHN
WINSUN
Elanco
Virbac
Jinyu Bio-Technology
ChengDu Tecbond
CAVAC
Kyoto Biken Laboratories
Market segment by region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Cattle and Sheep Vaccine product scope, market overview, market estimation caveats and base year.
Chapter 2, to profile the top manufacturers of Cattle and Sheep Vaccine, with price, sales, revenue and global market share of Cattle and Sheep Vaccine from 2018 to 2023.
Chapter 3, the Cattle and Sheep Vaccine competitive situation, sales quantity, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Cattle and Sheep Vaccine breakdown data are shown at the regional level, to show the sales quantity, consumption value and growth by regions, from 2018 to 2029.
Chapter 5 and 6, to segment the sales by Type and application, with sales market share and growth rate by type, application, from 2018 to 2029.
Chapter 7, 8, 9, 10 and 11, to break the sales data at the country level, with sales quantity, consumption value and market share for key countries in the world, from 2017 to 2022.and Cattle and Sheep Vaccine market forecast, by regions, type and application, with sales and revenue, from 2024 to 2029.
Chapter 12, market dynamics, drivers, restraints, trends, Porters Five Forces analysis, and Influence of COVID-19 and Russia-Ukraine War.
Chapter 13, the key raw materials and key suppliers, and industry chain of Cattle and Sheep Vaccine.
Chapter 14 and 15, to describe Cattle and Sheep Vaccine sales channel, distributors, customers, research findings and conclusion.

世界の市場調査レポート販売サイト（H&Iグローバルリサーチ株式会社運営）
*** レポート目次（コンテンツ）***

1 Market Overview
1.1 Product Overview and Scope of Cattle and Sheep Vaccine
1.2 Market Estimation Caveats and Base Year
1.3 Market Analysis by Type
1.3.1 Overview: Global Cattle and Sheep Vaccine Consumption Value by Type: 2018 Versus 2022 Versus 2029
1.3.2 Live Attenuated Vaccines
1.3.3 Inactivated Vaccines
1.3.4 Other
1.4 Market Analysis by Application
1.4.1 Overview: Global Cattle and Sheep Vaccine Consumption Value by Application: 2018 Versus 2022 Versus 2029
1.4.2 Cattle
1.4.3 Sheep
1.5 Global Cattle and Sheep Vaccine Market Size & Forecast
1.5.1 Global Cattle and Sheep Vaccine Consumption Value (2018 & 2022 & 2029)
1.5.2 Global Cattle and Sheep Vaccine Sales Quantity (2018-2029)
1.5.3 Global Cattle and Sheep Vaccine Average Price (2018-2029)
2 Manufacturers Profiles
2.1 Merck
2.1.1 Merck Details
2.1.2 Merck Major Business
2.1.3 Merck Cattle and Sheep Vaccine Product and Services
2.1.4 Merck Cattle and Sheep Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.1.5 Merck Recent Developments/Updates
2.2 Zoetis
2.2.1 Zoetis Details
2.2.2 Zoetis Major Business
2.2.3 Zoetis Cattle and Sheep Vaccine Product and Services
2.2.4 Zoetis Cattle and Sheep Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.2.5 Zoetis Recent Developments/Updates
2.3 Boehringer Ingelheim
2.3.1 Boehringer Ingelheim Details
2.3.2 Boehringer Ingelheim Major Business
2.3.3 Boehringer Ingelheim Cattle and Sheep Vaccine Product and Services
2.3.4 Boehringer Ingelheim Cattle and Sheep Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.3.5 Boehringer Ingelheim Recent Developments/Updates
2.4 Ceva
2.4.1 Ceva Details
2.4.2 Ceva Major Business
2.4.3 Ceva Cattle and Sheep Vaccine Product and Services
2.4.4 Ceva Cattle and Sheep Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.4.5 Ceva Recent Developments/Updates
2.5 CAHIC
2.5.1 CAHIC Details
2.5.2 CAHIC Major Business
2.5.3 CAHIC Cattle and Sheep Vaccine Product and Services
2.5.4 CAHIC Cattle and Sheep Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.5.5 CAHIC Recent Developments/Updates
2.6 HVRI
2.6.1 HVRI Details
2.6.2 HVRI Major Business
2.6.3 HVRI Cattle and Sheep Vaccine Product and Services
2.6.4 HVRI Cattle and Sheep Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.6.5 HVRI Recent Developments/Updates
2.7 Ringpu Biology
2.7.1 Ringpu Biology Details
2.7.2 Ringpu Biology Major Business
2.7.3 Ringpu Biology Cattle and Sheep Vaccine Product and Services
2.7.4 Ringpu Biology Cattle and Sheep Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.7.5 Ringpu Biology Recent Developments/Updates
2.8 Yebio
2.8.1 Yebio Details
2.8.2 Yebio Major Business
2.8.3 Yebio Cattle and Sheep Vaccine Product and Services
2.8.4 Yebio Cattle and Sheep Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.8.5 Yebio Recent Developments/Updates
2.9 DHN
2.9.1 DHN Details
2.9.2 DHN Major Business
2.9.3 DHN Cattle and Sheep Vaccine Product and Services
2.9.4 DHN Cattle and Sheep Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.9.5 DHN Recent Developments/Updates
2.10 WINSUN
2.10.1 WINSUN Details
2.10.2 WINSUN Major Business
2.10.3 WINSUN Cattle and Sheep Vaccine Product and Services
2.10.4 WINSUN Cattle and Sheep Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.10.5 WINSUN Recent Developments/Updates
2.11 Elanco
2.11.1 Elanco Details
2.11.2 Elanco Major Business
2.11.3 Elanco Cattle and Sheep Vaccine Product and Services
2.11.4 Elanco Cattle and Sheep Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.11.5 Elanco Recent Developments/Updates
2.12 Virbac
2.12.1 Virbac Details
2.12.2 Virbac Major Business
2.12.3 Virbac Cattle and Sheep Vaccine Product and Services
2.12.4 Virbac Cattle and Sheep Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.12.5 Virbac Recent Developments/Updates
2.13 Jinyu Bio-Technology
2.13.1 Jinyu Bio-Technology Details
2.13.2 Jinyu Bio-Technology Major Business
2.13.3 Jinyu Bio-Technology Cattle and Sheep Vaccine Product and Services
2.13.4 Jinyu Bio-Technology Cattle and Sheep Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.13.5 Jinyu Bio-Technology Recent Developments/Updates
2.14 ChengDu Tecbond
2.14.1 ChengDu Tecbond Details
2.14.2 ChengDu Tecbond Major Business
2.14.3 ChengDu Tecbond Cattle and Sheep Vaccine Product and Services
2.14.4 ChengDu Tecbond Cattle and Sheep Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.14.5 ChengDu Tecbond Recent Developments/Updates
2.15 CAVAC
2.15.1 CAVAC Details
2.15.2 CAVAC Major Business
2.15.3 CAVAC Cattle and Sheep Vaccine Product and Services
2.15.4 CAVAC Cattle and Sheep Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.15.5 CAVAC Recent Developments/Updates
2.16 Kyoto Biken Laboratories
2.16.1 Kyoto Biken Laboratories Details
2.16.2 Kyoto Biken Laboratories Major Business
2.16.3 Kyoto Biken Laboratories Cattle and Sheep Vaccine Product and Services
2.16.4 Kyoto Biken Laboratories Cattle and Sheep Vaccine Sales Quantity, Average Price, Revenue, Gross Margin and Market Share (2018-2023)
2.16.5 Kyoto Biken Laboratories Recent Developments/Updates
3 Competitive Environment: Cattle and Sheep Vaccine by Manufacturer
3.1 Global Cattle and Sheep Vaccine Sales Quantity by Manufacturer (2018-2023)
3.2 Global Cattle and Sheep Vaccine Revenue by Manufacturer (2018-2023)
3.3 Global Cattle and Sheep Vaccine Average Price by Manufacturer (2018-2023)
3.4 Market Share Analysis (2022)
3.4.1 Producer Shipments of Cattle and Sheep Vaccine by Manufacturer Revenue ($MM) and Market Share (%): 2022
3.4.2 Top 3 Cattle and Sheep Vaccine Manufacturer Market Share in 2022
3.4.2 Top 6 Cattle and Sheep Vaccine Manufacturer Market Share in 2022
3.5 Cattle and Sheep Vaccine Market: Overall Company Footprint Analysis
3.5.1 Cattle and Sheep Vaccine Market: Region Footprint
3.5.2 Cattle and Sheep Vaccine Market: Company Product Type Footprint
3.5.3 Cattle and Sheep Vaccine Market: Company Product Application Footprint
3.6 New Market Entrants and Barriers to Market Entry
3.7 Mergers, Acquisition, Agreements, and Collaborations
4 Consumption Analysis by Region
4.1 Global Cattle and Sheep Vaccine Market Size by Region
4.1.1 Global Cattle and Sheep Vaccine Sales Quantity by Region (2018-2029)
4.1.2 Global Cattle and Sheep Vaccine Consumption Value by Region (2018-2029)
4.1.3 Global Cattle and Sheep Vaccine Average Price by Region (2018-2029)
4.2 North America Cattle and Sheep Vaccine Consumption Value (2018-2029)
4.3 Europe Cattle and Sheep Vaccine Consumption Value (2018-2029)
4.4 Asia-Pacific Cattle and Sheep Vaccine Consumption Value (2018-2029)
4.5 South America Cattle and Sheep Vaccine Consumption Value (2018-2029)
4.6 Middle East and Africa Cattle and Sheep Vaccine Consumption Value (2018-2029)
5 Market Segment by Type
5.1 Global Cattle and Sheep Vaccine Sales Quantity by Type (2018-2029)
5.2 Global Cattle and Sheep Vaccine Consumption Value by Type (2018-2029)
5.3 Global Cattle and Sheep Vaccine Average Price by Type (2018-2029)
6 Market Segment by Application
6.1 Global Cattle and Sheep Vaccine Sales Quantity by Application (2018-2029)
6.2 Global Cattle and Sheep Vaccine Consumption Value by Application (2018-2029)
6.3 Global Cattle and Sheep Vaccine Average Price by Application (2018-2029)
7 North America
7.1 North America Cattle and Sheep Vaccine Sales Quantity by Type (2018-2029)
7.2 North America Cattle and Sheep Vaccine Sales Quantity by Application (2018-2029)
7.3 North America Cattle and Sheep Vaccine Market Size by Country
7.3.1 North America Cattle and Sheep Vaccine Sales Quantity by Country (2018-2029)
7.3.2 North America Cattle and Sheep Vaccine Consumption Value by Country (2018-2029)
7.3.3 United States Market Size and Forecast (2018-2029)
7.3.4 Canada Market Size and Forecast (2018-2029)
7.3.5 Mexico Market Size and Forecast (2018-2029)
8 Europe
8.1 Europe Cattle and Sheep Vaccine Sales Quantity by Type (2018-2029)
8.2 Europe Cattle and Sheep Vaccine Sales Quantity by Application (2018-2029)
8.3 Europe Cattle and Sheep Vaccine Market Size by Country
8.3.1 Europe Cattle and Sheep Vaccine Sales Quantity by Country (2018-2029)
8.3.2 Europe Cattle and Sheep Vaccine Consumption Value by Country (2018-2029)
8.3.3 Germany Market Size and Forecast (2018-2029)
8.3.4 France Market Size and Forecast (2018-2029)
8.3.5 United Kingdom Market Size and Forecast (2018-2029)
8.3.6 Russia Market Size and Forecast (2018-2029)
8.3.7 Italy Market Size and Forecast (2018-2029)
9 Asia-Pacific
9.1 Asia-Pacific Cattle and Sheep Vaccine Sales Quantity by Type (2018-2029)
9.2 Asia-Pacific Cattle and Sheep Vaccine Sales Quantity by Application (2018-2029)
9.3 Asia-Pacific Cattle and Sheep Vaccine Market Size by Region
9.3.1 Asia-Pacific Cattle and Sheep Vaccine Sales Quantity by Region (2018-2029)
9.3.2 Asia-Pacific Cattle and Sheep Vaccine Consumption Value by Region (2018-2029)
9.3.3 China Market Size and Forecast (2018-2029)
9.3.4 Japan Market Size and Forecast (2018-2029)
9.3.5 Korea Market Size and Forecast (2018-2029)
9.3.6 India Market Size and Forecast (2018-2029)
9.3.7 Southeast Asia Market Size and Forecast (2018-2029)
9.3.8 Australia Market Size and Forecast (2018-2029)
10 South America
10.1 South America Cattle and Sheep Vaccine Sales Quantity by Type (2018-2029)
10.2 South America Cattle and Sheep Vaccine Sales Quantity by Application (2018-2029)
10.3 South America Cattle and Sheep Vaccine Market Size by Country
10.3.1 South America Cattle and Sheep Vaccine Sales Quantity by Country (2018-2029)
10.3.2 South America Cattle and Sheep Vaccine Consumption Value by Country (2018-2029)
10.3.3 Brazil Market Size and Forecast (2018-2029)
10.3.4 Argentina Market Size and Forecast (2018-2029)
11 Middle East & Africa
11.1 Middle East & Africa Cattle and Sheep Vaccine Sales Quantity by Type (2018-2029)
11.2 Middle East & Africa Cattle and Sheep Vaccine Sales Quantity by Application (2018-2029)
11.3 Middle East & Africa Cattle and Sheep Vaccine Market Size by Country
11.3.1 Middle East & Africa Cattle and Sheep Vaccine Sales Quantity by Country (2018-2029)
11.3.2 Middle East & Africa Cattle and Sheep Vaccine Consumption Value by Country (2018-2029)
11.3.3 Turkey Market Size and Forecast (2018-2029)
11.3.4 Egypt Market Size and Forecast (2018-2029)
11.3.5 Saudi Arabia Market Size and Forecast (2018-2029)
11.3.6 South Africa Market Size and Forecast (2018-2029)
12 Market Dynamics
12.1 Cattle and Sheep Vaccine Market Drivers
12.2 Cattle and Sheep Vaccine Market Restraints
12.3 Cattle and Sheep Vaccine Trends Analysis
12.4 Porters Five Forces Analysis
12.4.1 Threat of New Entrants
12.4.2 Bargaining Power of Suppliers
12.4.3 Bargaining Power of Buyers
12.4.4 Threat of Substitutes
12.4.5 Competitive Rivalry
12.5 Influence of COVID-19 and Russia-Ukraine War
12.5.1 Influence of COVID-19
12.5.2 Influence of Russia-Ukraine War
13 Raw Material and Industry Chain
13.1 Raw Material of Cattle and Sheep Vaccine and Key Manufacturers
13.2 Manufacturing Costs Percentage of Cattle and Sheep Vaccine
13.3 Cattle and Sheep Vaccine Production Process
13.4 Cattle and Sheep Vaccine Industrial Chain
14 Shipments by Distribution Channel
14.1 Sales Channel
14.1.1 Direct to End-User
14.1.2 Distributors
14.2 Cattle and Sheep Vaccine Typical Distributors
14.3 Cattle and Sheep Vaccine Typical Customers
15 Research Findings and Conclusion
16 Appendix
16.1 Methodology
16.2 Research Process and Data Source
16.3 Disclaimer

List of Tables
Table 1. Global Cattle and Sheep Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Table 2. Global Cattle and Sheep Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Table 3. Merck Basic Information, Manufacturing Base and Competitors
Table 4. Merck Major Business
Table 5. Merck Cattle and Sheep Vaccine Product and Services
Table 6. Merck Cattle and Sheep Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 7. Merck Recent Developments/Updates
Table 8. Zoetis Basic Information, Manufacturing Base and Competitors
Table 9. Zoetis Major Business
Table 10. Zoetis Cattle and Sheep Vaccine Product and Services
Table 11. Zoetis Cattle and Sheep Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 12. Zoetis Recent Developments/Updates
Table 13. Boehringer Ingelheim Basic Information, Manufacturing Base and Competitors
Table 14. Boehringer Ingelheim Major Business
Table 15. Boehringer Ingelheim Cattle and Sheep Vaccine Product and Services
Table 16. Boehringer Ingelheim Cattle and Sheep Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 17. Boehringer Ingelheim Recent Developments/Updates
Table 18. Ceva Basic Information, Manufacturing Base and Competitors
Table 19. Ceva Major Business
Table 20. Ceva Cattle and Sheep Vaccine Product and Services
Table 21. Ceva Cattle and Sheep Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 22. Ceva Recent Developments/Updates
Table 23. CAHIC Basic Information, Manufacturing Base and Competitors
Table 24. CAHIC Major Business
Table 25. CAHIC Cattle and Sheep Vaccine Product and Services
Table 26. CAHIC Cattle and Sheep Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 27. CAHIC Recent Developments/Updates
Table 28. HVRI Basic Information, Manufacturing Base and Competitors
Table 29. HVRI Major Business
Table 30. HVRI Cattle and Sheep Vaccine Product and Services
Table 31. HVRI Cattle and Sheep Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 32. HVRI Recent Developments/Updates
Table 33. Ringpu Biology Basic Information, Manufacturing Base and Competitors
Table 34. Ringpu Biology Major Business
Table 35. Ringpu Biology Cattle and Sheep Vaccine Product and Services
Table 36. Ringpu Biology Cattle and Sheep Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 37. Ringpu Biology Recent Developments/Updates
Table 38. Yebio Basic Information, Manufacturing Base and Competitors
Table 39. Yebio Major Business
Table 40. Yebio Cattle and Sheep Vaccine Product and Services
Table 41. Yebio Cattle and Sheep Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 42. Yebio Recent Developments/Updates
Table 43. DHN Basic Information, Manufacturing Base and Competitors
Table 44. DHN Major Business
Table 45. DHN Cattle and Sheep Vaccine Product and Services
Table 46. DHN Cattle and Sheep Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 47. DHN Recent Developments/Updates
Table 48. WINSUN Basic Information, Manufacturing Base and Competitors
Table 49. WINSUN Major Business
Table 50. WINSUN Cattle and Sheep Vaccine Product and Services
Table 51. WINSUN Cattle and Sheep Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 52. WINSUN Recent Developments/Updates
Table 53. Elanco Basic Information, Manufacturing Base and Competitors
Table 54. Elanco Major Business
Table 55. Elanco Cattle and Sheep Vaccine Product and Services
Table 56. Elanco Cattle and Sheep Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 57. Elanco Recent Developments/Updates
Table 58. Virbac Basic Information, Manufacturing Base and Competitors
Table 59. Virbac Major Business
Table 60. Virbac Cattle and Sheep Vaccine Product and Services
Table 61. Virbac Cattle and Sheep Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 62. Virbac Recent Developments/Updates
Table 63. Jinyu Bio-Technology Basic Information, Manufacturing Base and Competitors
Table 64. Jinyu Bio-Technology Major Business
Table 65. Jinyu Bio-Technology Cattle and Sheep Vaccine Product and Services
Table 66. Jinyu Bio-Technology Cattle and Sheep Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 67. Jinyu Bio-Technology Recent Developments/Updates
Table 68. ChengDu Tecbond Basic Information, Manufacturing Base and Competitors
Table 69. ChengDu Tecbond Major Business
Table 70. ChengDu Tecbond Cattle and Sheep Vaccine Product and Services
Table 71. ChengDu Tecbond Cattle and Sheep Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 72. ChengDu Tecbond Recent Developments/Updates
Table 73. CAVAC Basic Information, Manufacturing Base and Competitors
Table 74. CAVAC Major Business
Table 75. CAVAC Cattle and Sheep Vaccine Product and Services
Table 76. CAVAC Cattle and Sheep Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 77. CAVAC Recent Developments/Updates
Table 78. Kyoto Biken Laboratories Basic Information, Manufacturing Base and Competitors
Table 79. Kyoto Biken Laboratories Major Business
Table 80. Kyoto Biken Laboratories Cattle and Sheep Vaccine Product and Services
Table 81. Kyoto Biken Laboratories Cattle and Sheep Vaccine Sales Quantity (K Units), Average Price (US$/Unit), Revenue (USD Million), Gross Margin and Market Share (2018-2023)
Table 82. Kyoto Biken Laboratories Recent Developments/Updates
Table 83. Global Cattle and Sheep Vaccine Sales Quantity by Manufacturer (2018-2023) & (K Units)
Table 84. Global Cattle and Sheep Vaccine Revenue by Manufacturer (2018-2023) & (USD Million)
Table 85. Global Cattle and Sheep Vaccine Average Price by Manufacturer (2018-2023) & (US$/Unit)
Table 86. Market Position of Manufacturers in Cattle and Sheep Vaccine, (Tier 1, Tier 2, and Tier 3), Based on Consumption Value in 2022
Table 87. Head Office and Cattle and Sheep Vaccine Production Site of Key Manufacturer
Table 88. Cattle and Sheep Vaccine Market: Company Product Type Footprint
Table 89. Cattle and Sheep Vaccine Market: Company Product Application Footprint
Table 90. Cattle and Sheep Vaccine New Market Entrants and Barriers to Market Entry
Table 91. Cattle and Sheep Vaccine Mergers, Acquisition, Agreements, and Collaborations
Table 92. Global Cattle and Sheep Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 93. Global Cattle and Sheep Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 94. Global Cattle and Sheep Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 95. Global Cattle and Sheep Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 96. Global Cattle and Sheep Vaccine Average Price by Region (2018-2023) & (US$/Unit)
Table 97. Global Cattle and Sheep Vaccine Average Price by Region (2024-2029) & (US$/Unit)
Table 98. Global Cattle and Sheep Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 99. Global Cattle and Sheep Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 100. Global Cattle and Sheep Vaccine Consumption Value by Type (2018-2023) & (USD Million)
Table 101. Global Cattle and Sheep Vaccine Consumption Value by Type (2024-2029) & (USD Million)
Table 102. Global Cattle and Sheep Vaccine Average Price by Type (2018-2023) & (US$/Unit)
Table 103. Global Cattle and Sheep Vaccine Average Price by Type (2024-2029) & (US$/Unit)
Table 104. Global Cattle and Sheep Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 105. Global Cattle and Sheep Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 106. Global Cattle and Sheep Vaccine Consumption Value by Application (2018-2023) & (USD Million)
Table 107. Global Cattle and Sheep Vaccine Consumption Value by Application (2024-2029) & (USD Million)
Table 108. Global Cattle and Sheep Vaccine Average Price by Application (2018-2023) & (US$/Unit)
Table 109. Global Cattle and Sheep Vaccine Average Price by Application (2024-2029) & (US$/Unit)
Table 110. North America Cattle and Sheep Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 111. North America Cattle and Sheep Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 112. North America Cattle and Sheep Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 113. North America Cattle and Sheep Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 114. North America Cattle and Sheep Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 115. North America Cattle and Sheep Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 116. North America Cattle and Sheep Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 117. North America Cattle and Sheep Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 118. Europe Cattle and Sheep Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 119. Europe Cattle and Sheep Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 120. Europe Cattle and Sheep Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 121. Europe Cattle and Sheep Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 122. Europe Cattle and Sheep Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 123. Europe Cattle and Sheep Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 124. Europe Cattle and Sheep Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 125. Europe Cattle and Sheep Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 126. Asia-Pacific Cattle and Sheep Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 127. Asia-Pacific Cattle and Sheep Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 128. Asia-Pacific Cattle and Sheep Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 129. Asia-Pacific Cattle and Sheep Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 130. Asia-Pacific Cattle and Sheep Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 131. Asia-Pacific Cattle and Sheep Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 132. Asia-Pacific Cattle and Sheep Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 133. Asia-Pacific Cattle and Sheep Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 134. South America Cattle and Sheep Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 135. South America Cattle and Sheep Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 136. South America Cattle and Sheep Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 137. South America Cattle and Sheep Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 138. South America Cattle and Sheep Vaccine Sales Quantity by Country (2018-2023) & (K Units)
Table 139. South America Cattle and Sheep Vaccine Sales Quantity by Country (2024-2029) & (K Units)
Table 140. South America Cattle and Sheep Vaccine Consumption Value by Country (2018-2023) & (USD Million)
Table 141. South America Cattle and Sheep Vaccine Consumption Value by Country (2024-2029) & (USD Million)
Table 142. Middle East & Africa Cattle and Sheep Vaccine Sales Quantity by Type (2018-2023) & (K Units)
Table 143. Middle East & Africa Cattle and Sheep Vaccine Sales Quantity by Type (2024-2029) & (K Units)
Table 144. Middle East & Africa Cattle and Sheep Vaccine Sales Quantity by Application (2018-2023) & (K Units)
Table 145. Middle East & Africa Cattle and Sheep Vaccine Sales Quantity by Application (2024-2029) & (K Units)
Table 146. Middle East & Africa Cattle and Sheep Vaccine Sales Quantity by Region (2018-2023) & (K Units)
Table 147. Middle East & Africa Cattle and Sheep Vaccine Sales Quantity by Region (2024-2029) & (K Units)
Table 148. Middle East & Africa Cattle and Sheep Vaccine Consumption Value by Region (2018-2023) & (USD Million)
Table 149. Middle East & Africa Cattle and Sheep Vaccine Consumption Value by Region (2024-2029) & (USD Million)
Table 150. Cattle and Sheep Vaccine Raw Material
Table 151. Key Manufacturers of Cattle and Sheep Vaccine Raw Materials
Table 152. Cattle and Sheep Vaccine Typical Distributors
Table 153. Cattle and Sheep Vaccine Typical Customers
List of Figures
Figure 1. Cattle and Sheep Vaccine Picture
Figure 2. Global Cattle and Sheep Vaccine Consumption Value by Type, (USD Million), 2018 & 2022 & 2029
Figure 3. Global Cattle and Sheep Vaccine Consumption Value Market Share by Type in 2022
Figure 4. Live Attenuated Vaccines Examples
Figure 5. Inactivated Vaccines Examples
Figure 6. Other Examples
Figure 7. Global Cattle and Sheep Vaccine Consumption Value by Application, (USD Million), 2018 & 2022 & 2029
Figure 8. Global Cattle and Sheep Vaccine Consumption Value Market Share by Application in 2022
Figure 9. Cattle Examples
Figure 10. Sheep Examples
Figure 11. Global Cattle and Sheep Vaccine Consumption Value, (USD Million): 2018 & 2022 & 2029
Figure 12. Global Cattle and Sheep Vaccine Consumption Value and Forecast (2018-2029) & (USD Million)
Figure 13. Global Cattle and Sheep Vaccine Sales Quantity (2018-2029) & (K Units)
Figure 14. Global Cattle and Sheep Vaccine Average Price (2018-2029) & (US$/Unit)
Figure 15. Global Cattle and Sheep Vaccine Sales Quantity Market Share by Manufacturer in 2022
Figure 16. Global Cattle and Sheep Vaccine Consumption Value Market Share by Manufacturer in 2022
Figure 17. Producer Shipments of Cattle and Sheep Vaccine by Manufacturer Sales Quantity ($MM) and Market Share (%): 2021
Figure 18. Top 3 Cattle and Sheep Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 19. Top 6 Cattle and Sheep Vaccine Manufacturer (Consumption Value) Market Share in 2022
Figure 20. Global Cattle and Sheep Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 21. Global Cattle and Sheep Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 22. North America Cattle and Sheep Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 23. Europe Cattle and Sheep Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 24. Asia-Pacific Cattle and Sheep Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 25. South America Cattle and Sheep Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 26. Middle East & Africa Cattle and Sheep Vaccine Consumption Value (2018-2029) & (USD Million)
Figure 27. Global Cattle and Sheep Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 28. Global Cattle and Sheep Vaccine Consumption Value Market Share by Type (2018-2029)
Figure 29. Global Cattle and Sheep Vaccine Average Price by Type (2018-2029) & (US$/Unit)
Figure 30. Global Cattle and Sheep Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 31. Global Cattle and Sheep Vaccine Consumption Value Market Share by Application (2018-2029)
Figure 32. Global Cattle and Sheep Vaccine Average Price by Application (2018-2029) & (US$/Unit)
Figure 33. North America Cattle and Sheep Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 34. North America Cattle and Sheep Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 35. North America Cattle and Sheep Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 36. North America Cattle and Sheep Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 37. United States Cattle and Sheep Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 38. Canada Cattle and Sheep Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 39. Mexico Cattle and Sheep Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 40. Europe Cattle and Sheep Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 41. Europe Cattle and Sheep Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 42. Europe Cattle and Sheep Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 43. Europe Cattle and Sheep Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 44. Germany Cattle and Sheep Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 45. France Cattle and Sheep Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 46. United Kingdom Cattle and Sheep Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 47. Russia Cattle and Sheep Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 48. Italy Cattle and Sheep Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 49. Asia-Pacific Cattle and Sheep Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 50. Asia-Pacific Cattle and Sheep Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 51. Asia-Pacific Cattle and Sheep Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 52. Asia-Pacific Cattle and Sheep Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 53. China Cattle and Sheep Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 54. Japan Cattle and Sheep Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 55. Korea Cattle and Sheep Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 56. India Cattle and Sheep Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 57. Southeast Asia Cattle and Sheep Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 58. Australia Cattle and Sheep Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 59. South America Cattle and Sheep Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 60. South America Cattle and Sheep Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 61. South America Cattle and Sheep Vaccine Sales Quantity Market Share by Country (2018-2029)
Figure 62. South America Cattle and Sheep Vaccine Consumption Value Market Share by Country (2018-2029)
Figure 63. Brazil Cattle and Sheep Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 64. Argentina Cattle and Sheep Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 65. Middle East & Africa Cattle and Sheep Vaccine Sales Quantity Market Share by Type (2018-2029)
Figure 66. Middle East & Africa Cattle and Sheep Vaccine Sales Quantity Market Share by Application (2018-2029)
Figure 67. Middle East & Africa Cattle and Sheep Vaccine Sales Quantity Market Share by Region (2018-2029)
Figure 68. Middle East & Africa Cattle and Sheep Vaccine Consumption Value Market Share by Region (2018-2029)
Figure 69. Turkey Cattle and Sheep Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 70. Egypt Cattle and Sheep Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 71. Saudi Arabia Cattle and Sheep Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 72. South Africa Cattle and Sheep Vaccine Consumption Value and Growth Rate (2018-2029) & (USD Million)
Figure 73. Cattle and Sheep Vaccine Market Drivers
Figure 74. Cattle and Sheep Vaccine Market Restraints
Figure 75. Cattle and Sheep Vaccine Market Trends
Figure 76. Porters Five Forces Analysis
Figure 77. Manufacturing Cost Structure Analysis of Cattle and Sheep Vaccine in 2022
Figure 78. Manufacturing Process Analysis of Cattle and Sheep Vaccine
Figure 79. Cattle and Sheep Vaccine Industrial Chain
Figure 80. Sales Quantity Channel: Direct to End-User vs Distributors
Figure 81. Direct Channel Pros & Cons
Figure 82. Indirect Channel Pros & Cons
Figure 83. Methodology
Figure 84. Research Process and Data Source

※参考情報

牛・羊ワクチンは、家畜の健康管理においてとても重要な役割を果たす生物製剤であり、特に牛や羊のような反芻動物に対する病気の予防や制御を目的としています。これらのワクチンは、免疫系に働きかけることで、特定の感染症への耐性を持たせることを目指しています。牛や羊は、農業や畜産業において経済的な価値を持つため、これらの動物の健康を維持することは、農業経済や食品の安全性に直接的に関わってきます。

まず、牛・羊ワクチンの基本的な概念について述べていきます。牛や羊に対するワクチンは、一般的に病原体（ウイルス、細菌など）を模倣した成分を含んでいます。それにより、動物の免疫系はこの病原体を認識し、抗体を生成します。これが、将来的に実際の病原体に遭遇した際に必須な防御反応をもたらします。このようなワクチンは、予防接種として定期的に投与されるものと、発症のリスクが高い際に使用されるものに分類されます。

牛・羊ワクチンの特徴には、複数の種類が存在することが挙げられます。主に、無毒化生ワクチン、組換えワクチン、そして不活化ワクチンの三つのカテゴリーに分類されます。無毒化生ワクチンは、病原性を持たないが感染性を保持する生きた微生物を用いたもので、効果が高い反面、管理が難しい場合があります。組換えワクチンは、遺伝子工学を利用して作成されたもので、特定のタンパク質を含むことで、免疫反応を誘発します。これらは、通常、安全性が高く、特定の病原体に対する精密な応答を引き起こすことができます。不活化ワクチンは、病原体を死滅させてから使用します。これらは一般的に安全性が高いですが、免疫応答が生ワクチンよりも弱い場合があります。

それでは、牛・羊ワクチンの具体的な用途について説明します。主な用途としては、風土病の予防が挙げられます。例えば、牛においては、口蹄疫、牛伝染性鼻気管炎、そして牛白血病ウイルスなどがあり、羊においては、ブルセラ病やショートノーズ病などが影響を及ぼすことがあります。これらの病気は、感染が広がると畜産業に大きな影響を与えるため、ワクチン接種を通じてこれらの病気の発生を未然に防ぐことが求められます。

また、牛・羊ワクチンは、抗生物質の使用を減少させる助けにもなります。感染症が蔓延すると、病気を治療するために抗生物質が多く使用されがちですが、これが耐性菌の発生を引き起こすことがあります。ワクチンによって疾病を防ぐことで、抗生物質の使用を最小限に抑えることができ、長期的に見て動物の健康を守ることに繋がります。

さらに、牛・羊ワクチンの関連技術についても触れておく必要があります。最近では、ワクチン開発において遺伝子工学やナノテクノロジーが活用されています。これにより、より高効率かつ安全なワクチンの開発が期待されています。また、デジタル技術による管理システムも整備されつつあり、ワクチンの効果を分析し、最適な接種時期や方法を科学的に決定することが可能になっています。これによって、ワクチンの投与が一層効果的かつ効率的になるでしょう。

牛・羊ワクチンの導入にはいくつかの取り組みが不可欠です。まず、農家や獣医師への教育と普及が重要です。さまざまな病気やそれに対するワクチンの重要性、接種スケジュールについての理解を深めることが、ワクチン接種が行き渡るためには欠かせません。さらに、政府や関連機関が進める監視プログラムや研究が必要です。正確なデータの収集とそれに基づく方針の策定が、牛・羊ワクチンの効果を最大限に引き出すことに貢献します。

牛・羊ワクチンは、畜産業の持続可能性を考える上でも重要な役割を果たしています。資源の利用を最適化し、経済的な安定を図る上で、ワクチンによる予防医学の位置付けは広がりを見せています。さらに、食の安全性を考慮する際にも、ワクチンによる感染症の予防は必要不可欠です。これにより、消費者が安心して牛肉や羊肉を食すことができる環境が整います。

しかしながら、ワクチンに対する誤解や抵抗感も未だ存在しています。予防接種の重要性や、その科学的根拠を広めていくことは、これからの畜産業において取り組むべき重要課題の一つです。牛・羊ワクチンの理解が深まることで、全体としての畜産業が持続的に成長することが期待されます。

以上のように、牛・羊ワクチンは、畜産業の発展に欠かせない重要な要素です。これにより、動物の健康維持、経済的安定、そして食の安全を実現するための取り組みが、今後さらに進展していくことを願っています。是非ともこの分野に関する理解を深め、広めていくことが求められるでしょう。


*** 免責事項 ***
https://www.globalresearch.co.jp/disclaimer/
※関連調査資料
  • 世界の羊＆山羊ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の五価ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界のスプリット・インフルエンザ・ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界のペット用狂犬病ワクチン市場2023年：企業・地域・タイプ・用途別分析
  • 世界の麻疹・おたふく風邪・風疹ウイルス生ワクチン市場2023年：企業・地域・タイプ・用途別分析
    • ※注目の調査資料
     ※当サイト上のレポートデータは弊社H&Iグローバルリサーチ運営のMarketReport.jpサイトと連動しています。
    ※当市場調査資料(GIR23JU614 )"世界の牛・羊ワクチン市場2023年：企業・地域・タイプ・用途別分析" (英文：Global Cattle and Sheep Vaccine Market 2023 by Manufacturers, Regions, Type and Application, Forecast to 2029)はGlobalInfoResearch社が調査・発行しており、H&Iグローバルリサーチが販売します。

    ◆H&Iグローバルリサーチのお客様（例）◆


    ※当サイトに掲載していない調査資料も弊社を通してご購入可能ですので、お気軽にご連絡ください。ウェブサイトでは紹介しきれない資料も数多くございます。
    ※無料翻訳ツールをご利用いただけます。翻訳可能なPDF納品ファイルが対象です。ご利用を希望されるお客様はご注文の時にその旨をお申し出ください。